PHS 2006-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
The summary for the PHS 2006-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44]) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
PHS 2006-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44]): The purpose of this FOA from NIH, CDC, and FDA is to invite eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) Phase I, Phase II, Fast-Track, and Phase II Competing Renewal grant applications through Grants.gov. SBIR Fast-Track and Phase II Competing Renewal grant applications are accepted by the NIH ONLY. This FOA will receive funds appropriated for fiscal years (FY) 2006 and 2007, the amounts for which are yet to be determined. However, the amounts set-aside by NIH, CDC, and FDA for FY 2005 SBIR awards were: NIH: $571 million; CDC: $8 million; and FDA: $800,000. There are three standard, annual submission dates for NIH, CDC, and FDA SBIR grant applications: April 1, August 1, and December 1 (May 1, September 1, and January 2 for NIH AIDS and AIDS-related applications). For planning purposes, the estimated number of SBIR awards for the FY 2006 cycles are: NIH: 950 awards; CDC: 15 awards; a! nd FDA: 2 awards. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, Fast-Track, and Phase II Competing Renewal applications, and runs in parallel with a FOA of identical scientific scope, PA-06-121, that solicits NIH applications under the Small Business Technology Transfer (STTR [R41/R42]) grant mechanisms. The CDC and the FDA do not participate in Fast-Track, Phase II Competing Renewal applications, and the STTR program.
| Federal Grant Title: | PHS 2006-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44]) |
| Federal Agency Name: | National Institutes of Health |
| Grant Categories: | Environment Education Health Income Security and Social Services Food and Nutrition |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | PA-06-120 |
| Type of Funding: | Grant |
| CFDA Numbers: | 93.06193.063 |
| CFDA Descriptions: | Innovations in Applied Public Health Research 93.063 Centers for Genomics and Public Health |
| Current Application Deadline: | No deadline provided |
| Original Application Deadline: | Multiple Receipt Dates - See Link to Full Announce |
| Posted Date: | Jan 20, 2006 |
| Creation Date: | Jan 20, 2006 |
| Archive Date: | Feb 02, 2007 |
| Total Program Funding: | |
| Maximum Federal Grant Award: | |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | |
| Cost Sharing or Matching: | 93.067 -- Global AIDS |
- Applicants Eligible for this Grant
- Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Foreign institutions are not eligible to apply. Only United States small business concerns (SBCs) are eligible to submit SBIR applications. A small business concern is one that, at the time of award, for both Phase I and Phase II awards, meets all of the following criteria: 1. Is independently owned and operated, is not dominant in the field of operation in which it is proposing, has a place of business in the United States and operates primarily within the United States or makes a significant contribution to the US economy, and is organized for profit. 2. Is (a) at least 51% owned and controlled by one or more individuals who are citizens of, or permanent resident aliens in, the United States, or (b) for SBIR only, it must be a for-profit business concern that is at least 51% owned and controlled by another for-profit business concern that is at least 51% owned and controlled by one or more individuals who are citizens of, or permane! nt resident aliens in, the United States. 3. Has, including its affiliates, an average number of employees for the preceding 12 months not exceeding 500, and meets the other regulatory requirements found in Title 13 Code of Federal Regulations (CFR) Part 121. Business concerns are generally considered to be affiliates of one another when either directly or indirectly, (a) one concern controls or has the power to control the other; or (b) a third-party/parties controls or has the power to control both.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster